Biohaven (BHVN) is up 6.1%, or $2.17 to $37.95.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BHVN:
- 3 Best Stocks to Buy Now, 12/17/2024, According to Top Analysts
- Biohaven reports clinical, regulatory milestones across MoDE platform
- Biohaven to present expanded safety data from BHV-7000 multiple-dose studies
- Biohaven price target raised to $61 from $58 at RBC Capital
- Scholar Rock price target raised to $45 from $36 at Truist